Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/27165
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fernando, Himawan | - |
dc.contributor.author | Duffy, Stephen J | - |
dc.contributor.author | Low, Ashlea | - |
dc.contributor.author | Dinh, Diem | - |
dc.contributor.author | Adrianopoulos, Nick | - |
dc.contributor.author | Sharma, Anand | - |
dc.contributor.author | Peter, Karlheinz | - |
dc.contributor.author | Stub, Dion | - |
dc.contributor.author | Leong, Kai'En | - |
dc.contributor.author | Ajani, Andrew | - |
dc.contributor.author | Clark, David J | - |
dc.contributor.author | Freeman, Melanie | - |
dc.contributor.author | Sebastian, Martin | - |
dc.contributor.author | Brennan, Angela | - |
dc.contributor.author | Selkrig, Laura | - |
dc.contributor.author | Reid, Christopher M | - |
dc.contributor.author | Kaye, David | - |
dc.contributor.author | Oqueli, Ernesto | - |
dc.date | 2021-08-03 | - |
dc.date.accessioned | 2021-08-09T05:49:13Z | - |
dc.date.available | 2021-08-09T05:49:13Z | - |
dc.date.issued | 2021-10-01 | - |
dc.identifier.citation | The American Journal of Cardiology 2021; 156: 52-57 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/27165 | - |
dc.description.abstract | The short- and long-term implications of identifying totally occluded culprit coronary arteries (TOCCA) in patients presenting with non-ST-elevation myocardial infarction (NSTEMI) have not been well studied. This study compares clinical characteristics, short- and long-term outcomes of patients with NSTEMI identified with TOCCA to that of patients with non-TOCCA undergoing percutaneous coronary intervention (PCI). We analyzed data from patients with NSTEMI undergoing single-vessel PCI within the Melbourne Interventional Group multi-center registry between 2005 and 2017. Those with TOCCA were compared to those with non-TOCCA. The primary endpoint was 30-day major adverse cardiac events (MACE). Secondary endpoints included 12-month MACE and long-term mortality. A total of 6,829 patients with NSTEMI had single-vessel PCI of which 954 (14%) had TOCCA. Most TOCCA were non-left anterior descending (right coronary artery 39% versus circumflex 33% versus left anterior descending 26%; p <0.001). Cardiogenic shock and left ventricular dysfunction were higher in the TOCCA group, but non-TOCCA patients had more baseline comorbidities. Thirty-day MACE was higher in the TOCCA group (6.7% versus 3.8%; p <0.001). Long-term mortality with an average follow-up of 4.9 years was higher in the non-TOCCA group (12% versus 18%, p <0.01). Multivariable Cox-proportional hazards regression identified TOCCA as an independent predictor of 30-day MACE (HR = 1.93; 95%CI: 1.4-2.6), but not long-term mortality, which was predicted by baseline comorbidities. In conclusion, while patients with NSTEMI with TOCCA undergoing PCI represent a more unstable subgroup early on, long-term outcomes appear more dependent on baseline comorbidities. | en |
dc.language.iso | eng | |
dc.subject | Myocardial Infarction | en |
dc.subject | Percutaneous Coronary Intervention | en |
dc.title | Totally Occluded Culprit Coronary Artery in Patients with Non-ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | The American Journal of Cardiology | en |
dc.identifier.affiliation | School of Public Health, Curtin University, Perth, Western Australia, Australia | en |
dc.identifier.affiliation | Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Department of Cardiology, Box Hill Hospital, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Cardiology | en |
dc.identifier.affiliation | Department of Cardiology, Barwon Health, Geelong, Victoria, Australia | en |
dc.identifier.affiliation | Department of Cardiology, Alfred Hospital, Melbourne, Australia | en |
dc.identifier.affiliation | Centre of Cardiovascular Research and Education in Therapeutics (CCRE), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia | en |
dc.identifier.affiliation | Baker Heart and Diabetes Institute, Melbourne, Australia | en |
dc.identifier.affiliation | Department of Cardiology, Ballarat Health Services, Ballarat, Victoria, Australia | en |
dc.identifier.affiliation | Central Clinical School, Monash University, Melbourne, Australia | en |
dc.identifier.affiliation | School of Medicine, Faculty of Health, Deakin University, Geelong, Victoria, Australia | en |
dc.identifier.doi | 10.1016/j.amjcard.2021.06.043 | en |
dc.type.content | Text | en |
dc.identifier.pubmedid | 34362552 | |
local.name.researcher | Clark, David J | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Cardiology | - |
crisitem.author.dept | University of Melbourne Clinical School | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.